NEWMOOD
A BIG PROJECT ON THE GENETICS OF DEPRESSION
120
million people worldwide suffer from depression and psychological therapies are
often more effective than drug treatments. At the Human Genome Meeting in
Berlin, Germany, was launched a massive project to probe the genetics of
depression: NEWMOOD. The study could lead to better animal models of
depression, aiding the testing of new therapies. Researchers will build a
microchip bearing 800 genes that may be related to depression, including those
affecting metabolism, growth and cell communication. The chip will detect which
genes are active in healthy and depressed animals and humans.
NEWMOOD
has 7.3 million euros of funding from the European Union. It will take place in
13 laboratories in ten countries over the next five years.
BM&L- April
2004